{"schema_version":"1","generated_at":"2026-11-04T23:39:52.337Z","data_as_of":null,"url":"https://www.findmykol.com/kol/larry-ebbert","json_url":"https://www.findmykol.com/kol/larry-ebbert/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"larry-ebbert","name":"Larry Ebbert","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Wailuku","state":"HI","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1518058163","openalex":"A5070255999"},"summary":"Larry Ebbert is an Oncology physician. OpenAlex indexes 21 publications with 1,597 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":21,"cited_by_count":1597,"h_index":14,"latest_activity_year":2023,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Pharmacyclics LLC, An AbbVie Company","program_year":2023,"amount_usd":31.67,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518058163"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1518058163","source":"payments"},"prescribing":{"data_year":2022,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":80,"classes_total":4,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":29.3,"drugs":[{"name":"Mekinist","share_pct":50},{"name":"Tafinlar","share_pct":50}],"max_beneficiaries":null},{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":18.7,"drugs":[{"name":"Letrozole","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":20,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":20,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2022,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":20,"shown":5,"withheld":15,"matched_by":"OpenAlex author record","recent":[{"title":"Randomized Comparison of a Nicotine Inhaler and Bupropion for Smoking Cessation and Relapse Prevention","year":2007,"journal":"Mayo Clinic Proceedings","source_url":"https://doi.org/10.1016/s0025-6196(11)60997-x","status":"verified"},{"title":"The prevalence of weight concerns in a smoking abstinence clinical trial","year":2005,"journal":"Addictive Behaviors","source_url":"https://doi.org/10.1016/j.addbeh.2005.08.011","status":"verified"},{"title":"A phase II study of aerosolized GM-CSF in the treatment of metastatic melanoma to the lung","year":2004,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.7571","status":"verified"},{"title":"Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting","year":2003,"journal":"Nicotine & Tobacco Research","source_url":"https://doi.org/10.1080/14622200307229","status":"verified"},{"title":"Randomized Phase II Study of Daily Versus Continuous-Infusion Schedules of Topotecan in the Treatment of Extensive-Stage Small Cell Lung Cancers","year":2003,"journal":"American Journal of Clinical Oncology","source_url":"https://doi.org/10.1097/01.coc.0000018038.28645.46","status":"verified"}],"source":"works"},"contact":{"address_1":"85 MAUI LANI PKWY","city":"Wailuku","state":"HI","zip":"967932416","phone":"808-442-5700","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1518058163","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":15}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-03-16","provider_certified":"2025-03-16","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}